RDW:NYSERedwire Corporation Analysis
Data as of 2026-09-09 - not real-time
$11.23
Latest Price
9/10Risk
Risk Level: High
Executive Summary
At $11.23, Redwire Corporation shows a bullish moving-average alignment, with shorter averages sitting above longer ones. The last 30 days have gained 27.2%. Momentum indicators put RSI at 50.1 (neutral) with MACD reading bearish. The recent range runs from support at $10.14 up to resistance at $14.19.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. Consensus targets land 30.8% above where the shares trade now. Revenue is growing at 89.6% on a -57.3% profit margin.
On a 1-10 scale the risk profile lands at 9 — high. With 30-day volatility of 87.4%, a beta of 3.90 and a maximum drawdown of 70.0%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
All three time horizons resolve to hold, carrying 1/10 conviction.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. Consensus targets land 30.8% above where the shares trade now. Revenue is growing at 89.6% on a -57.3% profit margin.
On a 1-10 scale the risk profile lands at 9 — high. With 30-day volatility of 87.4%, a beta of 3.90 and a maximum drawdown of 70.0%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
All three time horizons resolve to hold, carrying 1/10 conviction.
Top Market Events
Updated Aug 5, 2026 0 JACKSONVILLE, Fla.-- BUSINESS WIRE --Aug 5, 2026-- Redwire Corporation NYSE:RDW, “Redwire” or...JACKSONVILLE, Fla., August 05, 2026--Redwire Corporation NYSE:RDW, "Redwire" or the "Company" , a global leader in...RDW heads into Q2 earnings with 70.6% projected sales growth and record backlog, but R&D spending may pressure...
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 2/10
Key Factors
- Short-term moving averages stacked above long-term ones
- Trading above the 200-day average of 10.61
- MACD momentum is negative
Medium Term
1–3 yearsNeutral
Model confidence: 2/10
Key Factors
- Short-term moving averages stacked above long-term ones
- Trading above the 200-day average of 10.61
- Analyst targets imply +30.8% versus the current price
Long Term
> 3 yearsNeutral
Model confidence: 1/10
Key Factors
- Negative profit margin of -57.3%
- Analyst targets imply +30.8% versus the current price
- Negative return on equity of -18.2%
Key Metrics & Analysis
Financial Health
Revenue Growth89.60%
Profit Margin-57.26%
P/E Ratio-38.1
ROE-18.15%
ROA-6.10%
Debt/Equity5.54
P/B Ratio1.7
Op. Cash Flow$-76189000
Free Cash Flow$-25958376
Industry P/E28.3
Technical Analysis
TrendBullish
RSI50.1
Support$10.14
Resistance$14.19
MA 20$11.80
MA 50$10.77
MA 200$10.61
MACDBearish
VolumeDecreasing
Fear & Greed Index93.36
Valuation
Target Price$14.69
Upside/Downside30.79%
GradeFair
TypeGrowth
Risk Assessment
Beta3.90
Volatility87.39%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.